Scleroatrophic

Scleroatrophic is an adjective used in medical terminology to describe tissue changes that involve both sclerosis (hardening) and atrophy (thinning or wasting). The term derives from sclero- (hard) and atrophia (atrophy) and denotes a pattern of pathology rather than a single disease.

In clinical practice, scleroatrophy may describe skin and subcutaneous tissue where connective tissue becomes firm or fibrotic while the overlying tissue atrophies. It can occur in chronic inflammatory or autoimmune conditions, aging, or as a sequela of lipodystrophy, and may present as firm, waxy areas with reduced subcutaneous fat.

Pathophysiology often involves increased collagen deposition and fibrotic remodeling with loss of adipocytes and adnexal structures; microvascular dysfunction and chronic inflammation may contribute. Histology typically shows thickened, dense dermal or connective tissue with diminished fat and variable epidermal thinning.

Diagnosis is based on clinical assessment, with histology used to confirm the pattern when needed. Treatment focuses on managing the underlying condition and preserving function, with physical therapy and, when appropriate, immunomodulatory therapy. The prognosis depends on the cause and extent of involvement and may range from stable localized changes to progressive disease.